Gastric Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jan 7, 2005; 11(1): 46-50
Published online Jan 7, 2005. doi: 10.3748/wjg.v11.i1.46
Figure 1
Figure 1 Total NOS activity in gastric adenocarcinoma and normal tissues [pmole/(min·mg) protein].
Figure 2
Figure 2 Total NOS activity of gastric cancer by histological classification [pmole/(min·mg) protein]. Normal: normal gastric mucosa Well: well differentiated Moderate: moderately differentiated Poor: poorly differentiated.
Figure 3
Figure 3 Immunohistochemical strong staining for NOS in cytoplasm (SP), ×400. A: Expression of iNOS in gastric cancer cells; B: Expression of eNOS in gastric mucosal cells.
Figure 4
Figure 4 Expression of NOS mRNA in gastric cancer (ISH), ×400. A: Strong iNOS mRNA expression; B: Weak eNOS mRNA expression.
Figure 5
Figure 5 Immunohistochemical strong staining for p53 or PCNA in nuclei of gastric cancer cells (SP), ×400. A: p53 protein expression; B: PCNA protein expression.